Source: Eur Respir J 2014; 43: 1787-1790
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Galiana Antonio, Aguirre Estefania, Rodriguez Juan Carlos, Mira Alex, Santibañez Miguel, Candela Inmaculada, Llavero Juana, Garcinuño Pedro, López Francisco, Ruiz Montserrat, Garcia-Pachon Eduardo, Royo Gloria. Sputum microbiota in moderate versus severe patients with COPD. Eur Respir J 2014; 43: 1787-1790

Member's Comments

No comment yet.

Related content which might interest you: Bacterial flora in sputum and relationship with lung function in patients with acute exacerbation of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006 Factors associated with sputum purulence in stable moderate to severe COPD patients Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Cellular inflammatory pattern in induced sputum among patients with stable moderate or severe asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Sputum microbiome richness is decreased in patients treated for acute exacerbations of eosinophilic chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Sputum color as a marker for bacterial infection in severe acute exacerbations of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 240s Year: 2004 Lung function and bacterial pathogens in sputum of patients with acute exacerbation of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 408s Year: 2004 Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Variability and effects of bronchial colonisation in patients with moderate COPD Source: Eur Respir J 2010; 35: 295-302 Year: 2010 Impact of moderate and severe exacerbations in severe COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Common and atypical pathogens in severe COPD exacerbations and predictors of positive sputum cultures Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Blood eosinophil in smokers and mild and moderate COPD patients Source: International Congress 2017 – Latest insights into the management of chronic lung diseases Year: 2017 The relation between pathogenic bacteriology in sputum and lung function in patients with acute exacerbation of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 592s Year: 2002 Sputum neutrophilic markers in asthma of varying severity and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 550s Year: 2003 Gene expression in bronchial biopsies from mild to moderate COPD patients Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD Year: 2009 Effect of lower airway bacterial colonisation on time to acute exacerbation in patients with COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Sputum colour as a marker of acute bacterial exacerbations of COPD Source: Annual Congress 2003 - COPD - basic mechanisms and therapy of acute exacerbations Year: 2003 Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD exacerbations Year: 2014 Induced sputum concentrations of mucin in patients with asthma and chronic cough Source: Eur Respir J 2007; 30: Suppl. 51, 61s Year: 2007 Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020